Memphasys Limited (ASX:MEM)
0.0040
0.00 (0.00%)
At close: Nov 6, 2026
Memphasys Revenue
In the fiscal year ending June 30, 2026, Memphasys had annual revenue of 657.97K AUD with 24.87% growth. Memphasys had revenue of 645.56K in the half year ending June 30, 2026. That makes Memphasys the 44,677th largest company in the world by revenue and 1,049th in Australia.
Revenue
657.97K
Revenue Growth
+24.87%
P/S Ratio
18.82
Revenue / Employee
27.42K
Employees
24
Market Cap
12.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 657.97K | 131.05K | 24.87% |
| Jun 30, 2025 | 526.92K | 370.92K | 237.77% |
| Jun 30, 2024 | 156.00K | -468.37K | -75.01% |
| Jun 30, 2023 | 624.37K | 53.29K | 9.33% |
| Jun 30, 2022 | 571.08K | 359.60K | 170.04% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 34.87M |
| CleanSpace Holdings | 19.82M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| CurveBeam AI | 8.67M |
| CONNEQT Health | 7.90M |
| Atomo Diagnostics | 5.33M |
| OncoSil Medical | 5.09M |